Skip to main content
Skip to main content
BNKK logo

Bonk, Inc. (BNKK)

$1.45 $-0.03 (-2.03%) |Avoid · 16
Bottom line: SELL — our Council read (16/100) and AI Score (16/100) broadly agree. Strongest single signal: Seth Klarman bearish.
MCap: $7.96M| P/E Ratio: -0.3| Vol: 103.7K| 52-wk range: $1.81 – $46.90
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Bonk, Inc. (BNKK) trades at $1.45 with AI Score 16/100 (Grade F). Bonk, Inc. , operating as Safety Shot, Inc. , focuses on over-the-counter and consumer products, including its flagship Safety Shot Beverage designed to lower blood alcohol content. Market cap: $7.96M, Sector: Consumer defensive.

Price live · AI analysis from May 10, 2026
Bonk, Inc., operating as Safety Shot, Inc., focuses on over-the-counter and consumer products, including its flagship Safety Shot Beverage designed to lower blood alcohol content. The company also offers solutions for hair loss, vitiligo, eczema, and sexual wellness, distributing through direct sales, retailers, and e-commerce.

Analyst Coverage for BNKK: BNKK does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BNKK against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
SELL 16/100 · F

BNKK: 4/4 perspectives are bearish. Dominant signal: Seth Klarman bearish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Izzy Englander
Bearish
Seth Klarman
Bearish
Moon AI
Bearish
Council Score · 8 perspectives · See tabs for details →

Bonk, Inc. (BNKK) Consumer Business Overview

CEOJarrett A. Boon
Employees8
HeadquartersJupiter, FL, US
IPO Year2020

Bonk, Inc. (BNKK), under the brand Safety Shot, develops and distributes consumer products, including its flagship beverage targeting blood alcohol reduction. With a small team and a focus on e-commerce and retail channels, the company operates in the competitive non-alcoholic beverage sector, facing challenges in profitability and market penetration.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for BNKK?

Investing in Bonk, Inc. (BNKK) presents a high-risk, high-reward scenario. The company's focus on the Safety Shot Beverage, targeting blood alcohol reduction, could tap into a niche market. However, the company's negative profit margin of -1735.2% raises concerns about its financial sustainability. Key to the investment thesis is the successful market penetration of Safety Shot and the ability to scale production and distribution efficiently. The company's gross margin of 31.5% indicates potential profitability if sales volumes increase significantly. The high beta of 2.16 suggests significant volatility, reflecting the speculative nature of the stock. Growth catalysts include securing major retail partnerships and expanding the e-commerce presence. Investors should closely monitor sales figures, marketing effectiveness, and the company's ability to manage costs and achieve profitability.

Based on FMP financials and quantitative analysis

BNKK Key Highlights

  • Market capitalization of $7.96M indicates a micro-cap stock with high growth potential but also significant risk.
  • Negative profit margin of -1735.2% highlights the company's current lack of profitability and the need for significant operational improvements.
  • Gross margin of 31.5% suggests potential for profitability if the company can increase sales volume and reduce operating expenses.
  • Beta of 2.16 indicates high volatility, reflecting the speculative nature of the stock and its sensitivity to market fluctuations.
  • No dividend yield reflects the company's focus on reinvesting earnings for growth rather than returning capital to shareholders.

Who Are BNKK's Competitors?

BNKK is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
CHA Chagee Holdings Limited American Depositary Shares $11.01 -8.02% $2.10B 66
PRMB Primo Brands Corporation $25.02 +2.04% $9.08B 59
HAATF Haad Thip Public Company Limited $0.48 +0.00% $194.45M 57
CELH Celsius Holdings, Inc. $33.16 +4.05% $8.48B 56
FQVTF Fevertree Drinks PLC $10.89 -0.36% $1.23B 46
REED Reed's, Inc. $1.33 +3.10% $12.46M 46
OSHIF Oishi Group PLC $1.24 +0.00% 46
UPCHY Uni-President China Holdings Ltd $86.50 +0.00% $37.36M 46

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are BNKK's Key Strengths?

  • Unique product offering with Safety Shot Beverage.
  • Diverse product portfolio in health and wellness.
  • Multiple distribution channels.
  • Focus on over-the-counter solutions.

What Are BNKK's Weaknesses?

  • Negative profit margin.
  • Small employee base.
  • Limited brand awareness.
  • High beta indicating volatility.

What Could Drive BNKK Stock Higher?

  • Securing partnerships with major retail chains to expand distribution of Safety Shot Beverage.
  • Expansion of e-commerce platform and online marketing efforts to drive direct-to-consumer sales.
  • Launch of new health and wellness beverage products to diversify revenue streams.

What Are the Key Risks for BNKK?

  • Financial-distress signal — its Altman Z-Score of -11.08 sits in the distress zone (elevated bankruptcy risk).
  • High competition from established beverage companies and other health-focused brands.
  • Regulatory changes affecting the over-the-counter beverage and health product markets.
  • Negative profit margin and the need for significant operational improvements to achieve profitability.
  • Product liability claims related to the Safety Shot Beverage or other health and wellness products.

What Are the Growth Opportunities for BNKK?

  • Expansion of Retail Partnerships: Securing partnerships with major retail chains and convenience stores represents a significant growth opportunity for Bonk, Inc. Increased retail presence would enhance product visibility and accessibility to a broader customer base. The timeline for achieving this growth opportunity is within the next 12-24 months, contingent on successful negotiations and distribution agreements. The market size for retail sales of non-alcoholic beverages is substantial, offering significant revenue potential if Safety Shot can gain traction on store shelves.
  • E-commerce Channel Development: Enhancing the company's e-commerce platform and online marketing efforts can drive direct-to-consumer sales and expand its reach beyond traditional retail channels. Investing in targeted online advertising and social media campaigns can increase brand awareness and customer engagement. The e-commerce market for health and wellness products is growing rapidly, providing a favorable environment for Bonk, Inc. to capture online sales. This growth opportunity can be realized within the next 6-12 months with focused investment and strategic marketing initiatives.
  • Product Line Extension: Expanding the product line beyond Safety Shot to include other health and wellness beverages can diversify revenue streams and attract a wider range of customers. Developing new formulations targeting specific health needs or consumer preferences can create additional market opportunities. The timeline for product line expansion is within the next 18-36 months, requiring research and development efforts and market testing. The market for functional beverages is expanding, offering potential for Bonk, Inc. to capitalize on emerging trends.
  • International Market Expansion: Exploring opportunities to expand into international markets can unlock new growth potential and diversify the company's revenue base. Identifying countries with favorable regulatory environments and consumer demand for health and wellness products is crucial for successful international expansion. The timeline for international expansion is within the next 24-48 months, requiring market research, regulatory compliance, and distribution partnerships. The global market for non-alcoholic beverages is vast, offering significant long-term growth opportunities.
  • Strategic Acquisitions or Partnerships: Pursuing strategic acquisitions or partnerships with complementary businesses can accelerate growth and expand the company's capabilities. Acquiring companies with established distribution networks or complementary product lines can create synergies and enhance market position. The timeline for strategic acquisitions or partnerships is variable, depending on market conditions and available opportunities. The potential impact on growth is significant, with the ability to accelerate market penetration and expand product offerings.

What Opportunities Does BNKK Have?

  • Expansion of retail partnerships.
  • Growth in e-commerce sales.
  • Product line extension.
  • International market expansion.

What Threats Does BNKK Face?

  • Competition from established beverage companies.
  • Regulatory changes affecting over-the-counter products.
  • Fluctuations in consumer demand.
  • Potential for product liability claims.

What Are BNKK's Competitive Advantages?

  • Proprietary formulation of Safety Shot Beverage.
  • Brand recognition in the niche market of blood alcohol reduction products.
  • Established distribution network through direct sales, distributors, retailers, and e-commerce.

What Does BNKK Do?

Bonk, Inc., now known as Safety Shot, Inc., was founded in 2018 and is headquartered in Jupiter, Florida. The company's primary offering is the Safety Shot Beverage, an over-the-counter drink formulated to lower blood alcohol content. In addition to Safety Shot, the company provides a range of consumer products, including treatments for hair loss, vitiligo, eczema, and products aimed at enhancing sexual wellness. These products are distributed through various channels, including direct sales to customers, partnerships with distributors and retailers, and via e-commerce platforms. The rebranding to Safety Shot, Inc. in September 2023 reflects the company's strategic focus on its flagship beverage product. Bonk, Inc. aims to capture a segment of the market focused on health and wellness solutions, particularly targeting consumers seeking products that address specific health concerns and lifestyle enhancements. The company's ability to effectively market and distribute its products, especially Safety Shot, will be critical to its long-term success in the competitive consumer products landscape. With a small team of 8 employees, Bonk, Inc. faces the challenge of scaling its operations and expanding its market reach while maintaining product quality and customer satisfaction.

What Products and Services Does BNKK Offer?

  • Develops and markets the Safety Shot Beverage, an over-the-counter drink designed to lower blood alcohol content.
  • Offers hair loss treatment products.
  • Provides solutions for vitiligo.
  • Manufactures eczema cream.
  • Sells sexual wellness products.
  • Distributes products through direct sales, distributors, retailers, and e-commerce websites.

How Does BNKK Make Money?

  • Develops and manufactures over-the-counter health and wellness products.
  • Sells products directly to consumers through its website and other online platforms.
  • Partners with distributors and retailers to expand market reach.
  • Generates revenue through product sales.

What Industry Does BNKK Operate In?

Bonk, Inc. operates within the competitive non-alcoholic beverage sector, which is characterized by evolving consumer preferences and a focus on health and wellness. The market includes established players and emerging brands vying for market share through product innovation and effective marketing. Bonk, Inc.'s Safety Shot Beverage aims to carve out a niche by targeting consumers seeking to lower blood alcohol content. The company faces competition from traditional beverage companies and other health-focused brands. Success depends on effective branding, distribution, and demonstrating the efficacy of its products.

Who Are BNKK's Key Customers?

  • Individuals seeking to lower their blood alcohol content.
  • Consumers looking for hair loss treatments.
  • Individuals seeking solutions for vitiligo and eczema.
  • Customers interested in sexual wellness products.
AI Confidence: 64% Updated: May 10, 2026

Company Profile

Bonk, Inc. operates in the Beverages - Non-Alcoholic industry within the Consumer Defensive sector. It is headquartered in Jupiter, US. The company is led by CEO Jarrett A. Boon. BNKK has traded publicly since 2020.

Bonk, Inc. Financial Trajectory

Bonk, Inc. (BNKK) reported $4.3M in revenue for Q1 2026, reflecting 138.5% growth compared to the prior quarter. The company recorded a net loss of $1.8M, with diluted EPS of $-0.43. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Consumer Defensive. Across the four most recent quarters, BNKK averaged $-3.74 in diluted EPS.

How Bonk, Inc. Is Valued

Bonk, Inc. carries a market capitalization of $7.96M, placing it in the micro-cap category. Relative to its peer group, BNKK's quantitative score of 16/100 is below the peer average of 57/100.

F-Score 4/9Financial Health

Bonk, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -11.08 places it in the distress zone, a signal of elevated financial risk.

Net buyingInsider Activity

Over the past six months, Bonk, Inc. insiders filed 6 SEC Form 4 transactions — 0 sales and 6 purchases. On net that is roughly 53K shares acquired (about $119K) — insiders putting money in tends to read as conviction.

BNKK Financials

Fundamental Snapshot

Revenue Growth (FY)
+459.8%
Net Income Growth (FY)
-38.0%
EPS Growth (FY)
+50.1%
Free Cash Flow Growth (FY)
-36.2%
Return on Equity (TTM)
-155.0%
Current Ratio
1.3

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Unique product offering with Safety Shot Beverage.
  • Diverse product portfolio in health and wellness.
  • Multiple distribution channels.
  • Focus on over-the-counter solutions.

Bear Case

  • Negative profit margin.
  • Small employee base.
  • Limited brand awareness.
  • High beta indicating volatility.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q1 2026 $4M -$2M -$0.43
Q4 2025 $2M -$43M -$9.93
Q3 2025 $2M -$34M -$7.70
Q2 2025 $44,948 $13M $3.12

Based on FMP financials and quantitative analysis

BNKK Latest News

BNKK Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BNKK.

Price Targets

Wall Street price target analysis for BNKK.

BNKK MoonshotScore

16/100

What does this score mean?

The MoonshotScore rates BNKK's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Jarrett A. Boon

CEO

Jarrett A. Boon serves as the CEO of Bonk, Inc. (Safety Shot, Inc.). Information regarding his detailed career history and educational background is not available in the provided data. As CEO, he is responsible for leading the company's strategic direction, overseeing operations, and driving growth initiatives. His leadership is crucial for the company's success in the competitive consumer products market.

Track Record: With limited data available, it's challenging to assess Jarrett A. Boon's specific track record at Bonk, Inc. However, his role in rebranding the company to Safety Shot, Inc. in September 2023 indicates a strategic focus on the flagship beverage product. His ability to navigate the company towards profitability and market expansion will be key indicators of his success.

BNKK Consumer Defensive Stock FAQ

What does Bonk, Inc. do?

Bonk, Inc., operating as Safety Shot, Inc., develops, markets, and distributes over-the-counter health and wellness products, with a primary focus on its Safety Shot Beverage, designed to lower blood alcohol content. The company also offers solutions for hair loss, vitiligo, eczema, and sexual wellness. Its products are sold through direct sales, distributors, retailers, and e-commerce platforms, targeting consumers seeking convenient health and lifestyle solutions. The company aims to establish a strong presence in the competitive consumer products market by leveraging its unique product offerings and diverse distribution channels.

What do analysts say about BNKK stock?

Based on available data, there is no analyst coverage information provided for Bonk, Inc. (BNKK). Due to the limited market capitalization and financial performance, it is possible that the company does not have significant analyst coverage. Investors should conduct their own due diligence and consider the company's financial statements, market position, and growth prospects before making any investment decisions. The high beta of 2.16 indicates that the stock is highly volatile and may be subject to significant price fluctuations.

What are the main risks for BNKK?

Bonk, Inc. faces several key risks, including intense competition from established beverage companies and other health-focused brands, which could limit its market share and pricing power. Regulatory changes affecting the over-the-counter beverage and health product markets could impact the company's ability to market and sell its products. The company's negative profit margin poses a significant financial risk, requiring substantial operational improvements to achieve profitability. Additionally, product liability claims related to the Safety Shot Beverage or other health and wellness products could result in significant financial losses and reputational damage.

What are the key factors to evaluate for BNKK?

Bonk, Inc. (BNKK) holds an AI score of 16/100 (low). Not financial advice.

How frequently does BNKK data refresh on this page?

BNKK prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven BNKK's recent stock price performance?

Bonk, Inc. (BNKK) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Unique product offering with Safety Shot Beverage. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider BNKK overvalued or undervalued right now?

Valuing Bonk, Inc. (BNKK) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying BNKK?

Before investing in Bonk, Inc. (BNKK), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited financial data available.
  • Lack of analyst coverage information.
  • Small market capitalization and high volatility.
Data Sources

Popular Stocks